January 21, 2025 Maria Dranishnikova Former unicorn 23andMe reportedly selling its telehealth business, shares rise
January 20, 2025 Maria Dranishnikova Goldman Sachs raises target price for dermatological drug maker MoonLake by 32%
January 17, 2025 Maria Dranishnikova Outsmarting cancer: Why immune-oncology firm MAIA has 600% upside
January 16, 2025 Maria Dranishnikova Cancer therapy and vaccine maker GeoVax gains on progress in cancer drug trials
January 16, 2025 Maria Dranishnikova Royce Small-Cap Total Return Fund reveals biggest contributing and detracting holdings
January 15, 2025 Maria Dranishnikova Nvidia-backed data center builder Applied Digital to raise up to $5 billion; shares rise
January 15, 2025 Maria Dranishnikova Equipment rental company H&E doubles on announcement of its acquisition by rival
January 14, 2025 Maria Dranishnikova AI beauty solutions developer Perfect Corp. sees target price upgraded after acquisition of competitor
January 13, 2025 Maria Dranishnikova Gryphon, bitcoin miner with AI focus, gains on acquisition of energy asset
January 13, 2025 Maria Dranishnikova Fintech AtlasClear announces new strategy, sees shares slide to new all-time low
January 10, 2025 Maria Dranishnikova ‘We saved time’: CFO of satellite communications company Gilat discusses Stellar Blu acquisition and dot-com crisis lessons
January 9, 2025 Maria Dranishnikova Energy drink producer Yerbaé surges 20% after announcing acquisition by competitor
January 9, 2025 Maria Dranishnikova Shares of Sana soar following breakthrough in diabetes therapy trials
January 8, 2025 Maria Dranishnikova Achieve shares climb on positive smoking cessation therapy trial results
January 7, 2025 Maria Dranishnikova Citius Oncology spikes after hiring Jefferies to explore new strategies
January 6, 2025 Maria Dranishnikova Billionaire investor Carl Icahn increases his stake in fertilizer producer CVR Partners
January 6, 2025 Maria Dranishnikova The Motley Fool highlights three stocks that could double returns for investors